US Stock MarketDetailed Quotes

QGEN Qiagen NV

Watchlist
  • 39.150
  • -0.550-1.39%
Close Feb 26 16:00 ET
8.46BMarket Cap102.76P/E (TTM)

Qiagen NV Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Qiagen NV Q4 2024 Earnings Date

Currency：USDFeb 5, 2025

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
518.54M
521.20M
+2.66M
Beat Est.
+1.84%
+2.36%
+0.51%
EPS
0.81
0.40
-0.41
Miss Est.
+86.74%
-9.93%
-50.28%
Analyst Rating
Buy

Feb 26, 2025

Qiagen NV Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 11 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 506.411M--
--2025/Q1-- / 464.754M--
Feb 5, 20252024/Q4521.202M / 518.541M--
Nov 6, 20242024/Q3501.869M / 491.118M--
Jul 31, 20242024/Q2496.347M / 494.635M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 506.411M--
--2025/Q1-- / 464.754M--
Feb 5, 20252024/Q4521.202M / 518.541M--
Nov 6, 20242024/Q3501.869M / 491.118M--
Jul 31, 20242024/Q2496.347M / 494.635M--

Unlock Free Earnings Estimates

Qiagen NV Earnings Reports

  • Qiagen NV | 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 8, 2024 13:21 ET

  • Qiagen NV | 6-K: Report of foreign private issuer (related to financial reporting)

    Aug 2, 2024 15:55 ET

  • Qiagen NV | 6-K: Report of foreign private issuer (related to financial reporting)

    Aug 2, 2024 06:04 ET

  • Qiagen NV | 6-K: Report of foreign private issuer (related to financial reporting)

    May 1, 2024 15:25 ET

    • Read more

    Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Lantheus
    LNTH
    +16.49%
    Hutchmed (China)
    HCM
    +6.29%
    Workday
    WDAY
    +6.22%
    DexCom
    DXCM
    +1.80%
    LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
    LTGHY
    +0.62%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Feb 26, 2025

    Buy

    • Buy

      41.67%

    • Hold

      58.33%

    • Sell

      0.00%

    Price Target

    No Data